Newsroom

BOSTON UND HONGKONG--(BUSINESS WIRE)--Innorna, ein Biotechnologieunternehmen im klinischen Stadium, das mit seiner innovativen Lipid-Nanopartikel-Technologie (LNP) die mRNA-Therapeutika revolutioniert, gab heute bekannt, dass die US-amerikanische Food and Drug Administration (FDA) sowohl den Status als Rare Pediatric Disease Designation (RPDD) und Orphan Drug Designation (ODD) für sein in der Entwicklung befindliches mRNA-Therapeutikum IN013 zur Behandlung der Wilson-Krankheit (WD) erteilt hat....

BOSTON & HONG KONG--(BUSINESS WIRE)--Innorna, een biotechnologiebedrijf in een klinische fase dat met zijn innovatieve lipide nanodeeltjes (LNP) toedieningstechnologie een revolutie teweegbrengt in mRNA-therapieën, heeft vandaag aangekondigd dat de U.S. Food and Drug Administration (FDA) zowel de Rare Pediatric Disease Designation (RPDD) als de Orphan Drug Designation ( ODD ) heeft toegekend aan IN013, zijn onderzoekstherapie met mRNA, voor de behandeling van Wilson Disease (WD). Deze dubbele p...

BOSTON e HONG KONG--(BUSINESS WIRE)--Innorna, società biotecnologica allo stadio clinico che rivoluziona i medicinali a mRNA con la sua tecnologia innovativa di distribuzione delle nanoparticelle lipidiche (LNP), ha annunciato oggi che la Food and Drug Administration (FDA) statunitense ha assegnato entrambe la Designazione di malattia pediatrica rara (RPDD) e la Designazione di farmaco orfano ( ODD ) alla sua terapia sperimentale a mRNA, IN013, per il trattamento del morbo di Wilson (MW). La do...

紐約--(BUSINESS WIRE)--(美國商業資訊)-- 全球投資人權益法律事務所Rosen Law Firm提醒投資人，一名股東代表所有在2024年8月7日至2025年2月24日期間購買Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI)證券的投資人提起了集體訴訟。Maravai是一家生命科學公司，該公司提供的產品有助於開發藥物療法、診斷方法和新型疫苗，並為全球關於人類疾病的研究提供支援。 如欲瞭解更多資訊，請遞交表格、向Phillip Kim律師寄送電子郵件，或致電866-767-3653聯絡我們。 指控內容：Rosen Law Firm正在調查對Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI)在其業務營運方面誤導投資人的指控。 起訴書指稱，在集體訴訟期內，被告做出了虛假和/或誤導性陳述及/或未揭露：(1) Maravai在與營收確認相關的財務報告方面缺乏足夠的內部控制措施；(2)因此，Maravai在2024會計年度對某些交易的營收確認不準確；(3)其商譽被高估；以及(4)由...

纽约--(BUSINESS WIRE)--(美国商业资讯)-- 全球投资者权益律师事务所Rosen Law Firm提醒投资者，一名股东代表所有在2024年8月7日至2025年2月24日期间购买Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI)证券的投资者提起了集体诉讼。Maravai是一家生命科学公司，该公司提供的产品有助于开发药物疗法、诊断方法和新型疫苗，并为全球关于人类疾病的研究提供支持。 如需了解更多信息，请提交表格、向Phillip Kim律师发送电子邮件，或致电866-767-3653联系我们。 指控内容：Rosen Law Firm正在调查对Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI)在其业务运营方面误导投资者的指控。 起诉书指称，在集体诉讼期内，被告作出了虚假和/或误导性陈述及/或未披露：(1) Maravai在与营收确认相关的财务报告方面缺乏足够的内部控制措施；(2)因此，Maravai在2024财年对某些交易的营收确认不准确；(3)其商誉被高估；以及(4)由于上...

BOSTON et HONG KONG--(BUSINESS WIRE)--Innorna, une société de biotechnologie au stade clinique qui révolutionne les thérapies à base d’ARNm grâce à sa technologie innovante d’administration de nanoparticules lipidiques (LNP), a annoncé aujourd’hui que la Food and Drug Administration (FDA) des États-Unis a accordé la désignation de maladie pédiatrique rare (RPDD) et la désignation de médicament orphelin ( ODD ) à sa thérapie à base d’ARNm expérimentale, l’IN013, pour le traitement de la maladie...

BOSTON Y HONG KONG--(BUSINESS WIRE)--Innorna, una empresa de biotecnología en fase clínica que está revolucionando las terapias de ARNm con su innovadora tecnología de administración de nanopartículas lipídicas (LNP), ha anunciado hoy que la Food and Drug Administration (FDA) de EE.UU. ha concedido tanto la Rare Pediatric Disease Designation (RPDD) como la Orphan Drug Designation ( ODD ) a su terapia de investigación de ARNm, IN013, para el tratamiento de la enfermedad de Wilson (WD). Gracias a...

NEW YORK--(BUSINESS WIRE)--An innovative bin monitoring system that enables feed mill operators to access real-time bin levels, 24/7, eliminating the need for the hazardous practice of manual bin dropping is launching in the United States. LvLogics' SiloSpi system collects precise data on levels inside a bin or silo - and transmits it wirelessly to a secure cloud host. Feed millers understand that they need to keep their employees safe while at the same time operating effective inventory manage...

NOTTINGHAM, England--(BUSINESS WIRE)--Swissport International, a leading provider of ground services and cargo handling for the aviation sector, has announced a strategic partnership with global safety and quality software company Ideagen to accelerate their 2030 Vision of Zero Harm. This collaboration will enable Swissport to share information with governing bodies more easily to drive safety compliance. Ideagen's combined safety, quality and risk solution will be deployed across their 279 loc...

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, recently received congratulatory messages and unwavering outpouring of support from California political leaders on the Company’s Bridge Strategy, it’s FX brand and the recent appointment of YT Jia to the position of Co-CEO of the Company. The remarks were made at the Company’s recent ‘F...